Stock Trading Canary

Built: 2026-10-19T16:02:49+00:00 · 中文

← South Korea

SOUTH KOREA · OPENDART

ToolGen Incorporated

툴젠 · 199800 · KOSDAQ · Healthcare · Biotechnology

Score

Not ranked: no net buying on the exchange by an individual insider in the last 180 days.

Insider timeline

2 insiders bought in the last 180 days, 1 of them more than once.

KWON SOON ILKWON SOON ILMember of the executive committeeExecutiveRyu Jong SangRyu Jong SangChief Executive OfficerCEO / chairHyun Soon ChoHyun Soon ChoMember of the executive committeeExecutive2026-04-27 · KWON SOON IL · sale · 54,190,200 KRW2026-07-06 · Ryu Jong Sang · purchase · 9,021,750 KRW2026-07-27 · Ryu Jong Sang · purchase · 9,030,000 KRW2026-09-03 · Hyun Soon Cho · purchase · 10,458,000 KRWMayJunJulAugSepOct

Tap an item for what it means.

●A purchase: the bigger the dot, the more was bought

Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.

×A sale

A cross is one insider's sales on one day. People sell to pay tax, to cash in share awards or to hold less of one company, so a sale says less than a purchase does. When someone bought and sold on the same day, the cross sits beside the dot. The totals are under “Purchases against sales” below.

Blue line: this share's price, −70.1% over these six months

The closing price of each day, from 99,900.00 on 2026-04-21 to 29,850.00 on 2026-10-16. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.

Dashed line: the typical stock on the same exchange, −31.9%

Taken from the 1525 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −70.1%, the typical one −31.9%, 38.3 points behind. It is not an index and not a comparison within one industry.

This company: insiders buying per month, last 12 months

Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
1Jul
Aug
1Sep
Oct

Darker bars are inside the 180-day window above.

Who traded

InsiderRolePurchasesSalesBoughtFirst purchaseShare price since
KWON SOON ILExecutive—1———
Ryu Jong SangCEO / chair2—18.1M KRW2026-07-06−15.4%
Hyun Soon ChoExecutive1—10.5M KRW2026-09-03−10.6%

Purchases against sales

34%purchases
Purchases34%28.5M KRW · 3 line(s) · 2 insider(s)
Sales66%54.2M KRW · 1 line(s) · 1 insider(s)

Shares of the reported value of insider transactions in the 180-day window. Sales include disposals for tax, at option exercise or under a pre-set plan, which say little about an insider's view. The split describes what was disclosed; it is not a signal.

Insiders' buying price vs the latest close

Insiders paid 38,013.00 KRW a share on average (3 purchase lines, 2 buyers, 2026-07-06 – 2026-09-03). The close on 2026-10-16 was 21.5% below that price.

The latest purchase (2026-09-03) was at 34,860.00 KRW; the close was 14.4% below that price.

Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.

Insider trades on the exchange

Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.

Trade dateInsiderRoleTradeSharesPriceValueFiling
2026-09-03Hyun Soon ChoSenior managing directorBought on the exchange300₩34,860₩10.5MDART ↗
2026-07-27Ryu Jong SangCEOBought on the exchange200₩45,150₩9.0MDART ↗
2026-07-06Ryu Jong SangCEOBought on the exchange250₩36,087₩9.0MDART ↗
2026-04-27KWON SOON ILManaging directorSold on the exchange600₩90,317₩54.2MDART ↗
2026-01-07KWON SOON ILManaging directorSold on the exchange1,500₩59,106₩88.7MDART ↗
Other changes in holdings · 17

Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.

DateInsiderRoleReasonSharesFiling
2026-09-29Genexine, Inc10% shareholderOthers(-)9,660DART ↗
2026-09-29Genexine, Inc10% shareholderAcquisition of paid-in new shares(+)9,660DART ↗
2026-09-29JO JUNE SUNGManaging directorOthers(-)8DART ↗
2026-09-29JO JUNE SUNGManaging directorAcquisition of paid-in new shares(+)8DART ↗
2026-09-29KWON SOON ILManaging directorOthers(-)363DART ↗
2026-09-29KWON SOON ILManaging directorAcquisition of paid-in new shares(+)412DART ↗
2026-09-29Ryu Jong SangCEOOthers(-)38DART ↗
2026-09-29Ryu Jong SangCEOAcquisition of paid-in new shares(+)42DART ↗
2026-08-31Genexine, Inc10% shareholderDisposal in OTC(-)86,942DART ↗
2026-08-25Genexine, Inc10% shareholderOthers(+)96,602DART ↗
2026-08-25JO JUNE SUNGManaging directorOthers(+)8DART ↗
2026-08-25KWON SOON ILManaging directorOthers(+)363DART ↗
2026-08-25Ryu Jong SangCEOOthers(+)38DART ↗
2026-04-30KWON SOON ILManaging directorOthers(+)1,235DART ↗
2026-03-31Kim Jin SooNon-executive directorExecutive retirement(-)595,144DART ↗
2025-09-15Kim Jin SooNon-executive directorOthers(-)85,000DART ↗
2024-12-27Kim Jin SooNon-executive director신규선임(+)680,144DART ↗